Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Siderophore Genes on Cefiderocol Susceptibility in Carbapenem Resistant Hypervirulent Klebsiella Pneumoniae

NCT07475429 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07475429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07475429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Siderophore Genes on Cefiderocol Susceptibility in Carbapenem Resistant Hypervirulent Klebsiella Pneumoniae
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
March 15, 2026
Completion date
October 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carbapenem-resistant hypervirulent klebsiella pneumoniae infection